menu
    • menu

    Company profile for Edesa Biotech

    NEW Drugs in Dev: 4
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company founded by experts in the field of dermatology and gastroenterology. We are exploring new ways to treat these diseases, including alternatives to topical steroids, which can have serious side-effects. This innovative approach is made possible by proprietary technology developed to inhibit the inflammatory process at its inception rather than after inflammation h...
    Edesa Biotech, Inc. is a clinical-stage biopharmaceutical company founded by experts in the field of dermatology and gastroenterology. We are exploring new ways to treat these diseases, including alternatives to topical steroids, which can have serious side-effects. This innovative approach is made possible by proprietary technology developed to inhibit the inflammatory process at its inception rather than after inflammation has occurred. Our lead product candidate, EB01, is a non-steroidal, anti-inflammatory treatment for chronic allergic contact dermatitis.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Edesa BiotechCanada Flag
    Country
    Country
    Canada
    Address
    Address
    100 Spy Court Markham, Ontario L3R 5H6
    Telephone
    Telephone
    +1 289.800.9600
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.edesabiotech.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/edesa-biotech/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/EdesaBiotech

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    IPhEB Russia

    Not Confirmed

    envelop Contact Supplier

    IPhEB Russia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Edesa Bio To Present Oral Showcase At Respiratory Innovation
    Edesa Bio To Present Oral Showcase At Respiratory Innovation

    31 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/31/3266063/0/en/Edesa-Biotech-Invited-for-Oral-Showcase-at-Respiratory-Innovation-Summit.html

    GLOBENEWSWIRE
    31 Mar 2026
    Share Share
    Edesa Biotech Advances Vitiligo Program for Mid-2026 Enrollment
    Edesa Biotech Advances Vitiligo Program for Mid-2026 Enrollment

    26 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/26/3263120/0/en/Edesa-Biotech-Advances-Vitiligo-Program-for-Planned-Mid-2026-Enrollment.html

    GLOBENEWSWIRE
    26 Mar 2026
    Share Share
    Edesa Bio Reports More Phase 3 Paridiprubart Study Success
    Edesa Bio Reports More Phase 3 Paridiprubart Study Success

    24 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/24/3243711/0/en/Edesa-Biotech-Reports-Additional-Positive-Results-from-Phase-3-Paridiprubart-Study.html

    GLOBENEWSWIRE
    24 Feb 2026
    Share Share
    Edesa Biotech Reports Fiscal 1st Quarter 2026 Results
    Edesa Biotech Reports Fiscal 1st Quarter 2026 Results

    13 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/13/3238334/0/en/Edesa-Biotech-Reports-Fiscal-1st-Quarter-2026-Results.html

    GLOBENEWSWIRE
    13 Feb 2026
    Share Share
    Edesa Biotech Reports Fiscal Year 2025 Results
    Edesa Biotech Reports Fiscal Year 2025 Results

    12 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/12/3204872/0/en/Edesa-Biotech-Reports-Fiscal-Year-2025-Results.html

    GLOBENEWSWIRE
    12 Dec 2025
    Share Share
    Edesa Biotech Announces Upcoming Conference Schedule
    Edesa Biotech Announces Upcoming Conference Schedule

    31 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/31/3178656/0/en/Edesa-Biotech-Announces-Upcoming-Conference-Schedule.html

    GLOBENEWSWIRE
    31 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search